Testosterone levels dictate attraction

Sep 15, 2008
Testosterone levels dictate attraction

Women with higher levels of testosterone are more attracted to masculine looking men like celebrity beefcakes Russell Crowe and Daniel Craig.

And men with raised levels of the same hormone are more attracted to feminine looking faces like those of Lost star Evangeline Lilly and the actress Natalie Portman.

These are the findings of the University of Aberdeen's Face Research Laboratory which reveal that changes in testosterone levels affect the extent to which men and women are attracted to different types of faces.

It has been assumed that people are attracted to other people because they are drawn to particular types.

But Drs Ben Jones, Lisa DeBruine and Lisa Welling have shown that testosterone levels appear to be the key.

Theirs is the first study to reveal the role the hormone plays in making certain women attractive to certain men.

The researchers asked male and female volunteers to complete short face preference tests in which they were shown pairs of masculine and feminine faces. Participants were asked to choose which face from each pair was more attractive.

Men and women completed four different test sessions that were each a week apart. In each session, volunteers also provided a saliva sample which was used to measure testosterone levels.

Dr Jones, a Psychology lecturer, said: "People preferred different types of face in the session where their testosterone level was highest than in the session where it was lowest.

"When men's testosterone levels were high, they were more attracted to feminine women. When women's testosterone levels were high, they were more attracted to masculine men.

"Since masculine men and feminine women are thought to produce the healthiest children and sex drive is higher when testosterone levels are also high, these findings suggest that men and women in hormonal states where their interest in sex is highest, show stronger attraction to high quality – or healthy – mates."

Dr Welling added: "We tend to think that attraction is relatively stable over time. However, our research shows that attraction is affected by fluctuations in testosterone levels."

Drs Jones and DeBruine will be talking about their research at Innovate with Aberdeen, The Frontiers of Excellence which is taking place at the University of Aberdeen on Thursday, September 18, and is open to all.

Source: University of Aberdeen

Explore further: Hormonal therapy for transsexualism safe and effective

add to favorites email to friend print save as pdf

Related Stories

Climate talk shifts from curbing CO2 to adapting

2 hours ago

Efforts to curb global warming have quietly shifted as greenhouse gases inexorably rise. The conversation is no longer solely about how to save the planet by cutting carbon emissions. It's becoming more about ...

Divers begin Lake Michigan search for Griffin ship

2 hours ago

Divers began opening an underwater pit Saturday at a remote site in northern Lake Michigan that they say could be the resting place of the Griffin, a ship commanded by the 17th century French explorer La ...

Paris Air Show peek: Wide-body battle and drones

2 hours ago

The Paris Air Show, which opens for business on Monday Jun. 17, brings hundreds of aircraft to the skies around the French capital, the usual tense competition between aircraft manufacturers Boeing and Airbus, ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

Jun 18, 2013

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments : 0

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...